Sun Pharma Advanced Research Company Ltd Quarterly Result
Sun Pharma Advanced Research Company Ltd
NSE: SPARC
Net Profit - Last Quarter
Sun Pharma Advanced Research Company Ltd Quarterly Results Key Highlights
- The revenue of Sun Pharma Advanced Research Company Ltd for the Mar '26 is ₹ 1855 crore as compare to the Dec '25 revenue of ₹ 8.45 crore.
- This represent the growth of 21852% The ebitda of Sun Pharma Advanced Research Company Ltd for the Mar '26 is ₹ 1775 crore as compare to the Dec '25 ebitda of ₹ -69 crore.
- This represent the decline of -2672% The net profit of Sun Pharma Advanced Research Company Ltd for the Mar '26 is ₹ 1761 crore as compare to the Dec '25 net profit of ₹ -80.42 crore.
- This represent the decline of -2290%.
Sun Pharma Advanced Research Company Ltd Quarterly Results Analysis
Market Price of Sun Pharma Advanced Research Company Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date |  Price (₹) |
|---|---|
| 12 Jun 2026 | 223.4 |
| 11 Jun 2026 | 204 |
| 10 Jun 2026 | 205.8 |
| 09 Jun 2026 | 209.3 |
| 08 Jun 2026 | 203.65 |
| 05 Jun 2026 | 212.45 |
| 04 Jun 2026 | 212.9 |
| 03 Jun 2026 | 208.15 |
| 02 Jun 2026 | 204.05 |
| 01 Jun 2026 | 196.4 |
Historical Revenue of Sun Pharma Advanced Research Company Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
Historical Revenue of Sun Pharma Advanced Research Company Ltd
Historical EBITDA of Sun Pharma Advanced Research Company Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Sun Pharma Advanced Research Company Ltd
Historical Net Profit of Sun Pharma Advanced Research Company Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Sun Pharma Advanced Research Company Ltd
Sun Pharma Advanced Research Company Ltd News Hub
Sun Pharma Advanced Research Company reports consolidated net loss of Rs 95.90 crore in the June 2024 quarter
Net Loss of Sun Pharma Advanced Research Company reported to Rs 95.90 crore in the quarter ended Jun
Read more
05 Aug 24
Sun Pharma Advanced Research Company reports consolidated net loss of Rs 107.33 crore in the September 2024 quarter
Net Loss of Sun Pharma Advanced Research Company reported to Rs 107.33 crore in the quarter ended Se
Read more
04 Nov 24
Sun Pharma Advanced Research Company to convene board meeting
Sun Pharma Advanced Research Company will hold a meeting of the Board of Directors of the Company on
Read more
25 Oct 24
SPARC drops as Q2 net loss widens to Rs 107 crore
Net sales declined 39.29% year on year (YoY) to 12.86 crore in the quarter ended 30 September 2024.
Read more
04 Nov 24
Document
Annual Reports
Annual Report 2024
Credit Ratings
N/A
Concalls
Data not available
Data not available
Popular Search
About Sun Pharma Advanced Research Company Ltd
- Sun Pharma Advanced Research Company Limited (SPARC) is a clinical stage bio-pharmaceutical company engaged in creating new drugs and delivery systems.
- The Company works on innovation and new product development for global markets.
- They undertake projects in research and technology for new chemical entities (NCE's) or new molecules, and novel drug delivery systems (NDDS). Sun Pharmaceutical Advanced Research Company Limited was incorporated on March 1, 2006 as an innovative and development company.
- It commenced operations on March 22, 2006.
- As per Scheme of Arrangement, the entire business undertaking of the Innovative Research & Development including Novel Drug Delivery System (NDDS) Division of Sun Pharmaceuticals Industries' Research & Development Undertaking was transferred and vested into the Company effective from February 28, 2007.
FAQs for Quarterly Results of Sun Pharma Advanced Research Company Ltd
What key financial metrics are included in Sun Pharma Advanced Research Company Ltd's quarterly results?
When does Sun Pharma Advanced Research Company Ltd announce its quarterly results?
How does Sun Pharma Advanced Research Company Ltd's quarterly performance impact its stock price?
What is the impact of Sun Pharma Advanced Research Company Ltd's quarterly results on dividends?
Are there any special announcements usually made during Sun Pharma Advanced Research Company Ltd's quarterly results?
